Musculoskeletal Disorders Drugs Global Market Report 2018

Starting Price : $ 4000.00 | Pages : 125 | Published : February 2018 | SKU CODE : 3257 | Format :

The musculoskeletal system drugs market comprises companies that discover, develop, manufacture and distribute medications used in the treatment of musculoskeletal diseases. Musculoskeletal diseases include arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff tear, muscular dystrophy, myasthenia gravis, lupus erythematosus and others. Some of the major drugs in the market include piroxicam glaxo, dolonex, felden, and piroxicam Pfizer.

North America was the largest region in the musculoskeletal disorders drugs market in 2017, accounting for 32% market share. This can be attributed to the high per capita healthcare expenditure and the development of cost effective drugs for musculoskeletal disorders. Western Europe was the second largest region accounting for 22% market share. Africa was the smallest region accounting for 3% market share.

Introduction of advanced pain free drug delivery technologies is promoting the use of musculoskeletal drugs. Drug delivery systems refer to methods or processes used to administer a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery products such as intrathecal pumps are being used to deliver muscle relaxants such as baclofen directly into spinal cord to provide instant relief. Intra-Articular drug delivery systems are also widely being used to administer medicines to treat arthritis. In addition, these products reduce spasticity symptoms and lower the side effects caused by oral spasticity medications.

The companies covered are F. Hoffmann-La Roche Ltd, GlaxosmithKline Plc, Pfizer Inc, Abbott Laboratories Inc, and Daiichi Sankyo Company Limited.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The musculoskeletal disorders drugs market is segmented into Drugs For Rheumatoid Arthritis; Muscle Relaxants; and Others.

Drugs for Rheumatoid Arthritis are used in the treatment of rheumatoid arthritis to slow down the progression of disease.

Muscle Relaxants are drugs that act on the central nervous system to reduce pain associated with strains, sprains and muscle injuries.

Other Musculoskeletal Disorders Drugs include drugs used in treatment of osteoarthritis, analgesics, immunosupressives used in treatment of various musculoskeletal disorders.

Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion

Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say

Organs-on-Chips to Revolutionize the Drug Development Industry

Russia’s Musculoskeletal Drugs Market Is Catching Up With The Rest Of Europe

The Fastest Growing Regions for Dermatological Drug Sales Are the Middle East and South America

Growth of Middle Class Is Causing Heart Drugs Market In Asia Pacific To Accelerate, Says TBRC

8% Growth in Asia Pacific Presents Pharma Investors with Good Opportunities

Increasing Global Obesity And Stress Levels Mean Rapid Growth To Continue For Musculoskeletal Drugs Market

Blood Glucose Test Strips Global Market Report 2018

View Report

Veterinary Services Global Market Report 2018

View Report

Podiatry Services Global Market Strategies and Opportunities to 2021

View Report

Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021

View Report

Biologics Global Market Opportunities And Strategies To 2021

View Report

Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021

View Report

Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021

View Report

Veterinary Serices Global Market Opportunities And Strategies To 2021

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)